Vifor Pharma Ltd.

CIK 1416422 · last filed 2021-10-13

Vifor Pharma Ltd. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $473.2M of CCXI on Oct 13, 2021. Across all open-market trades the lifetime net is −$613.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $67.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$67.78M

Companies

1

Total Filings

5

Lifetime Open-Market Net

-$613.77M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CCXI	10%+ Owner	5,194,085	$13.05	$67.78M	-$613.77M	5	2021-10-13

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-10-13	CCXI	Sell (S)	−12,000,000	-$473.16M	EDGAR
2020-08-03	CCXI	Sell (S)	−413,223	-$22.20M	EDGAR
2020-07-29	CCXI	Sell (S)	−487,224	-$25.81M	EDGAR
2020-07-16	CCXI	Sell (S)	−779,394	-$45.32M	EDGAR
2020-07-08	CCXI	Sell (S)	−798,231	-$47.29M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.